Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety ...

Any patient on a dopamine receptor-blocking medication may develop tardive dyskinesia (TD), though most often the condition is associated with antipsychotic medications. "You would be ill-advised to ...

Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at least a month ...

Akathisia and tardive dyskinesia are neurological movement disorders that can develop as side effects of certain dopamine-blocking medications, particularly antipsychotics. Because both can involve ...

Tardive Dyskinesia (TD) is a serious, often misunderstood movement disorder that disproportionately affects Black patients. Caused by long-term use of certain medications, particularly antipsychotics, ...